A Comparative Study of Al18F-NOTA-LM3 Versus 68Ga-DOTATATE PET/CT for Tumor Detection in Patients With Pheochromocytoma and Paraganglioma
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The aim of this study is to evaluate the diagnostic performance of Al18F-NOTA-LM3 PET/CT and compare it with 68Ga-DOTATATE PET/CT in patients with pheochromocytoma/paraganglioma (PPGL).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• Patients aged 18 to 80 years.
• Suspected or confirmed PPGL patients.
Locations
Other Locations
China
Peking Union Medical College Hospital
RECRUITING
Beijing
Contact Information
Primary
Hongli Jing
annsmile1976@sina.com
18600586399
Backup
Yuwei Zhang
ywzhangwork@163.com
18511071577
Time Frame
Start Date: 2024-08-06
Estimated Completion Date: 2026-03-01
Participants
Target number of participants: 40
Treatments
Experimental: Al18F-NOTA-LM3 and 68Ga-DOTATATE PET/CT scan
Patients will perform an Al18F-NOTA-LM3 PET/CT as well as a 68Ga-DOTATATE PET/CT scan within one week, with a minimum 24-hour interval between scans.
Related Therapeutic Areas
Sponsors
Leads: Peking Union Medical College Hospital